 The goal of the study is to examine the difference of the pharmacokinetics of metformin with and without a 3 weeks pretreatment of St Johns Wort. Furthermore secondary objectives include changes in GLP-1, C-peptide, serum-insulin and plasma-glucose during an oral glucose tolerance test, changes in OCT1 mRNA in plasma and changes in leptin and lipid-profile following this possible interaction. 